2.2.1 Use of the facility: There is evidence that consideration has been given to future proofing the investment/facility/capacity/ model of care capability. patient need Will the design be appropriate for patient need? privacy and dignity Has the importance of privacy and dignity to individuals workflows and logistics been considered? adaptability security. 2.2.2 Describe and set out the access Consider way finding and signage, patients with requirements for patients, staff and disabilities, parking, goods and vehicle separation, and visitors. pedestrian access and exits. 2.2.3 Describe in the facility patient Describe and set out the arrangements for public clinical – space standards. 2.2.4 What is the impact of estates derogation Derogations must be approved by the medical and nurse on clinical care? directors of the organisation. 2.2.5 What is the impact of clinical Confirm that the health organisation has appointed a adjacencies in the scheme design? healthcare planner as part of the design team and this person has actively contributed to the planning and What consideration has been to the evaluation process. impact of clinical and non-clinical adjacencies in the scheme design? Describe the service backed by plans/drawings demonstrating clinical/non-clinical adjacencies.
2.2.1 Use of the facility: model of care patient need privacy and dignity workflows and logistics adaptability security. There is evidence that consideration has been given to future proofing the investment/facility/capacity/ capability. Will the design be appropriate for patient need? Has the importance of privacy and dignity to individuals been considered? 2.2.2 Describe and set out the access requirements for patients, staff and visitors. Consider way finding and signage, patients with disabilities, parking, goods and vehicle separation, and pedestrian access and exits. 2.2.3 Describe in the facility – patient space standards. Describe and set out the arrangements for public clinical 2.2.4 What is the impact of estates derogation on clinical care? Derogations must be approved by the medical and nurse directors of the organisation. 2.2.5 What is the impact of clinical adjacencies in the scheme design? What consideration has been to the impact of clinical and non-clinical adjacencies in the scheme design? Confirm that the health organisation has appointed a healthcare planner as part of the design team and this person has actively contributed to the planning and evaluation process. Describe the service backed by plans/drawings demonstrating clinical/non-clinical adjacencies.
NHSI_Capital_Regime_Investment_Annex_1_-_V5_final.docx